Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Dyer. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Dyer at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The purpose of this study is to assess the safety, tolerability, and efficacy of CBX-12 in female subjects with platinum resistant or refractory ovarian cancer at 2 doses; 125 mg/m2 every 21 days or 100 mg/m2 every 21 days.
Sponsor: Cybrexa Therapeutics
Check if you qualify for this ovarian cancer clinical trial in Dyer, IN
If you're searching for ovarian cancer treatment options in Dyer, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dyer research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.